SI1194140T1 - Farmacevtska zmes, ki vsebuje fenofibrat, in postopek priprave - Google Patents

Farmacevtska zmes, ki vsebuje fenofibrat, in postopek priprave

Info

Publication number
SI1194140T1
SI1194140T1 SI200030633T SI200030633T SI1194140T1 SI 1194140 T1 SI1194140 T1 SI 1194140T1 SI 200030633 T SI200030633 T SI 200030633T SI 200030633 T SI200030633 T SI 200030633T SI 1194140 T1 SI1194140 T1 SI 1194140T1
Authority
SI
Slovenia
Prior art keywords
pharmaceutical composition
surfactant
preparation
composition containing
cellulose derivative
Prior art date
Application number
SI200030633T
Other languages
English (en)
Inventor
Bruno Criere
Pascal Suplie
Philippe Chenevier
Original Assignee
Ethypharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9547923&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1194140(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm filed Critical Ethypharm
Publication of SI1194140T1 publication Critical patent/SI1194140T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
SI200030633T 1999-07-09 2000-07-07 Farmacevtska zmes, ki vsebuje fenofibrat, in postopek priprave SI1194140T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9908923A FR2795961B1 (fr) 1999-07-09 1999-07-09 Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
EP00949677A EP1194140B1 (fr) 1999-07-09 2000-07-07 Composition pharmaceutique contenant du fenofibrate et procede de preparation
PCT/FR2000/001971 WO2001003693A1 (fr) 1999-07-09 2000-07-07 Composition pharmaceutique contenant du fenofibrate et procede de preparation

Publications (1)

Publication Number Publication Date
SI1194140T1 true SI1194140T1 (sl) 2005-06-30

Family

ID=9547923

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200030633T SI1194140T1 (sl) 1999-07-09 2000-07-07 Farmacevtska zmes, ki vsebuje fenofibrat, in postopek priprave
SI200030894T SI1574214T1 (sl) 1999-07-09 2000-07-07 Farmacevtska zmes, ki vsebuje fenofibrat, in postopek njene izdelave

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200030894T SI1574214T1 (sl) 1999-07-09 2000-07-07 Farmacevtska zmes, ki vsebuje fenofibrat, in postopek njene izdelave

Country Status (37)

Country Link
US (4) US7101574B1 (sl)
EP (3) EP1194140B1 (sl)
JP (2) JP4841092B2 (sl)
KR (3) KR20020025188A (sl)
CN (2) CN1682707B (sl)
AT (3) ATE341320T1 (sl)
AU (1) AU782282B2 (sl)
BG (1) BG65504B1 (sl)
BR (1) BR0012335A (sl)
CA (1) CA2377909C (sl)
CY (1) CY1106206T1 (sl)
CZ (1) CZ300094B6 (sl)
DE (3) DE60039313D1 (sl)
DK (3) DK1574214T3 (sl)
EA (1) EA004294B1 (sl)
EE (1) EE04995B1 (sl)
ES (3) ES2235919T3 (sl)
FR (1) FR2795961B1 (sl)
GE (1) GEP20043287B (sl)
HK (3) HK1044894B (sl)
HR (1) HRP20020111B1 (sl)
HU (1) HU229044B1 (sl)
IL (2) IL147499A0 (sl)
IS (1) IS2157B (sl)
ME (1) ME01361B (sl)
MX (1) MXPA02000324A (sl)
NO (1) NO333301B1 (sl)
NZ (1) NZ516416A (sl)
PL (1) PL212082B1 (sl)
PT (3) PT1194140E (sl)
RS (1) RS50035B (sl)
SI (2) SI1194140T1 (sl)
SK (1) SK287484B6 (sl)
TR (1) TR200200008T2 (sl)
UA (1) UA72925C2 (sl)
WO (1) WO2001003693A1 (sl)
ZA (1) ZA200200169B (sl)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795961B1 (fr) * 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
US20080241070A1 (en) * 2000-09-21 2008-10-02 Elan Pharma International Ltd. Fenofibrate dosage forms
FR2819720B1 (fr) * 2001-01-22 2004-03-12 Fournier Lab Sa Nouveaux comprimes de fenofibrate
GB0119480D0 (en) 2001-08-09 2001-10-03 Jagotec Ag Novel compositions
EP2422772A3 (en) * 2002-09-20 2012-04-18 Alpharma, Inc. Sequestering subunit and related compositions and methods
WO2004028506A1 (en) * 2002-09-24 2004-04-08 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of fenofibrate having high bioavailability
CN100367947C (zh) * 2002-12-04 2008-02-13 徐州恩华赛德药业有限责任公司 具有抗高血脂症的含非诺贝特的药物组合物
RU2356549C2 (ru) * 2002-12-17 2009-05-27 Эббетт ГмбХ унд Ко.КГ Композиция, включающая фенофибриновую кислоту, ее физиологически приемлемую соль или производное
EP1829541A1 (en) * 2002-12-17 2007-09-05 Abbott GmbH & Co. KG Formulation comprising fenofibric acid or a physiologically acceptable salt thereof
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
WO2005002541A2 (en) * 2003-07-02 2005-01-13 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US7264813B2 (en) * 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US8026281B2 (en) * 2004-10-14 2011-09-27 Lupin Atlantis Holdings, S.A. Treating metabolic syndrome with fenofibrate
UA90708C2 (ru) * 2005-02-25 2010-05-25 Ф. Хоффманн-Ля Рош Аг Таблетки с улучшенной дисперсностью лекарственного вещества
EP1861084A1 (en) * 2005-03-30 2007-12-05 Teva Pharmaceutical Industries Ltd. Improved formulations of fenofibrate containing menthol or peg/poloxamer
US20080152714A1 (en) * 2005-04-08 2008-06-26 Yi Gao Pharmaceutical Formulations
WO2007134397A1 (en) * 2006-05-23 2007-11-29 Intelemetrix Ltd Data accessing system and method
HUE032156T2 (en) 2006-06-19 2017-09-28 Alpharma Pharmaceuticals Llc Pharmaceutical preparations
KR100767349B1 (ko) * 2006-08-01 2007-10-17 삼천당제약주식회사 페노피브레이트를 함유하는 경구용 약제 조성물 및 그의제조방법
EP1923053A1 (en) * 2006-09-27 2008-05-21 Novartis AG Pharmaceutical compositions comprising nilotinib or its salt
WO2008063301A2 (en) * 2006-10-11 2008-05-29 Alpharma, Inc. Pharmaceutical compositions
JP4993274B2 (ja) * 2006-12-05 2012-08-08 日医工株式会社 フェノフィブラート含有製剤組成物の製造方法
CA2709905A1 (en) * 2007-12-17 2009-06-25 Alfred Liang Abuse-resistant oxycodone composition
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
FR2940118B1 (fr) * 2008-12-24 2013-08-09 Ethypharm Sa Formulation pharmaceutique de fenofibrate nanonise
JPWO2010092925A1 (ja) * 2009-02-12 2012-08-16 あすか製薬株式会社 固体分散体とその医薬組成物、並びにそれらの製造方法
CN101502497B (zh) * 2009-03-06 2010-11-10 安徽省药物研究所 非诺贝特药物组合物
US20100291201A1 (en) * 2009-05-14 2010-11-18 Cerovene, Inc. Coated pharmaceutical capsule dosage form
KR101202994B1 (ko) * 2010-04-12 2012-11-21 한미사이언스 주식회사 페노피브린산 및 알칼리화제를 포함하는 경구용 약학 조성물
US20140255480A1 (en) * 2011-09-07 2014-09-11 Ethypharm Pharmaceutical formulation of nanonized fenofibrate
KR101334585B1 (ko) * 2012-05-29 2013-12-05 주식회사 브이터치 프로젝터를 통해 표시되는 정보를 이용하여 가상터치를 수행하는 원격 조작 장치 및 방법
US8722083B2 (en) 2012-06-25 2014-05-13 Mylan, Inc. Fenofibrate formulation
WO2014091318A1 (en) 2012-12-11 2014-06-19 Lupin Atlantis Holdings, S.A. Reduced dose pharmaceutical compositions of fenofibrate
BR112016011628A2 (pt) * 2013-12-04 2017-08-08 Dow Global Technologies Llc Processo para preparar uma mistura de um derivado de celulose e um diluente líquido
CN104352466A (zh) * 2014-11-17 2015-02-18 辰欣药业股份有限公司 一种非诺贝特组合物及其制剂
CN107961224B (zh) * 2017-12-06 2021-05-04 齐鲁制药(海南)有限公司 一种阿昔替尼片及其制备方法
KR102407512B1 (ko) 2019-10-30 2022-06-13 주식회사 대웅테라퓨틱스 피브레이트계 화합물을 포함하는 근육 질환 예방 및 치료용 조성물
CN112121022A (zh) * 2020-09-25 2020-12-25 迪沙药业集团有限公司 一种非诺贝特片组合物及其制备方法
WO2022071768A1 (en) * 2020-09-29 2022-04-07 Addpharma Inc. A pharmaceutical composition comprising fenofibrate particles with improved bioavailability
CN112121023A (zh) * 2020-09-30 2020-12-25 迪沙药业集团有限公司 一种非诺贝特片组合物

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH543472A (fr) 1969-01-31 1973-10-31 Orchimed Sa Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques
US4058552A (en) 1969-01-31 1977-11-15 Orchimed Sa Esters of p-carbonylphenoxy-isobutyric acids
GB1579818A (en) 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
DE2966564D1 (en) 1978-11-20 1984-02-23 American Home Prod Therapeutic compositions with enhanced bioavailability and process for their preparation
US4344934A (en) * 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
FR2494112B1 (sl) 1980-11-19 1986-01-10 Laruelle Claude
GB8414220D0 (en) 1984-06-04 1984-07-11 Sterwin Ag Medicaments in unit dose form
GB8414221D0 (en) 1984-06-04 1984-07-11 Sterwin Ag Unit dosage form
FR2602423B1 (fr) * 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
US4752470A (en) 1986-11-24 1988-06-21 Mehta Atul M Controlled release indomethacin
US4895725A (en) * 1987-08-24 1990-01-23 Clinical Technologies Associates, Inc. Microencapsulation of fish oil
FR2627696B1 (fr) 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
ATE105710T1 (de) 1990-07-02 1994-06-15 Boehringer Mannheim Gmbh Verfahren zur herstellung geformter, verpresster dosiseinheiten mit retardierter freisetzung und entsprechende dosiseinheit.
JP3125221B2 (ja) * 1990-09-01 2001-01-15 大正製薬株式会社 ソファルコン含有固形製剤
JP3037393B2 (ja) * 1990-10-22 2000-04-24 大正薬品工業株式会社 経口投与用固形薬剤の製造方法
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions
DE69127275T2 (de) * 1991-06-21 1998-03-12 Ilsan Ilac Ve Hammaddeleri San Neues galenisches Verfahren für Omeprazol enthaltende Pellets
SE9402422D0 (sv) 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
FR2722984B1 (fr) 1994-07-26 1996-10-18 Effik Lab Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate
US5558879A (en) * 1995-04-28 1996-09-24 Andrx Pharmaceuticals, Inc. Controlled release formulation for water soluble drugs in which a passageway is formed in situ
DE19608750A1 (de) 1996-03-06 1997-09-11 Durachemie Gmbh & Co Kg Verfahren zur Herstellung von Fenofibrat-Präparaten
CN1228693A (zh) * 1996-06-28 1999-09-15 先灵公司 含有三唑类抗真菌化合物的口服组合物
FR2758461A1 (fr) 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
EP1021525A1 (en) * 1997-12-20 2000-07-26 Genencor International, Inc. Fluidized bed matrix granule
JP2000086509A (ja) * 1998-09-14 2000-03-28 Taisho Yakuhin Kogyo Kk ソファルコン含有製剤の製造方法
FR2783421B1 (fr) * 1998-09-17 2000-11-24 Cll Pharma Procede de preparation de nouvelles formulations galeniques du fenofibrate, formulations galeniques obtenues par ledit procede et leurs applications
US6368620B2 (en) * 1999-06-11 2002-04-09 Abbott Laboratories Formulations comprising lipid-regulating agents
US7863331B2 (en) * 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2795961B1 (fr) * 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US6667064B2 (en) 2000-08-30 2003-12-23 Pilot Therapeutics, Inc. Composition and method for treatment of hypertriglyceridemia
AU6294501A (en) * 2000-09-20 2002-04-02 Rtp Pharma Inc Spray drying process and compositions of fenofibrate
US8026281B2 (en) * 2004-10-14 2011-09-27 Lupin Atlantis Holdings, S.A. Treating metabolic syndrome with fenofibrate

Also Published As

Publication number Publication date
ATE399006T1 (de) 2008-07-15
WO2001003693A1 (fr) 2001-01-18
SI1574214T1 (sl) 2006-12-31
CA2377909C (fr) 2011-06-28
ZA200200169B (en) 2002-07-31
NO20020014L (no) 2002-03-04
GEP20043287B (en) 2004-07-26
EP1523983B1 (fr) 2008-06-25
BR0012335A (pt) 2002-03-19
NO333301B1 (no) 2013-04-29
AU782282B2 (en) 2005-07-14
ATE341320T1 (de) 2006-10-15
PL212082B1 (pl) 2012-08-31
US8563042B2 (en) 2013-10-22
ES2309438T3 (es) 2008-12-16
EP1574214A1 (fr) 2005-09-14
EA200200147A1 (ru) 2002-06-27
EA004294B1 (ru) 2004-02-26
CN1360499A (zh) 2002-07-24
CZ300094B6 (cs) 2009-01-28
HK1044894A1 (en) 2002-11-08
HK1074588A1 (en) 2005-11-18
DE60031184D1 (de) 2006-11-16
KR20070026716A (ko) 2007-03-08
IS6218A (is) 2002-01-03
KR100766644B1 (ko) 2007-10-15
PT1523983E (pt) 2008-09-19
US20110159082A1 (en) 2011-06-30
DE60019120D1 (de) 2005-05-04
HU229044B1 (hu) 2013-07-29
NO20020014D0 (no) 2002-01-02
EP1194140B1 (fr) 2005-03-30
EP1194140A1 (fr) 2002-04-10
HRP20020111B1 (en) 2005-12-31
CZ20022A3 (cs) 2002-05-15
FR2795961A1 (fr) 2001-01-12
HK1044894B (zh) 2005-06-24
YU93201A (sh) 2004-09-03
CA2377909A1 (fr) 2001-01-18
UA72925C2 (uk) 2005-05-16
DK1194140T3 (da) 2005-07-04
CN1204885C (zh) 2005-06-08
US7101574B1 (en) 2006-09-05
ME01361B (me) 2008-11-28
BG65504B1 (bg) 2008-10-31
CY1106206T1 (el) 2011-06-08
HUP0202338A3 (en) 2003-03-28
DK1523983T3 (da) 2008-10-13
US8658212B2 (en) 2014-02-25
US20080248101A1 (en) 2008-10-09
KR20020025188A (ko) 2002-04-03
MXPA02000324A (es) 2002-06-21
JP2011148813A (ja) 2011-08-04
AU6296000A (en) 2001-01-30
SK152002A3 (en) 2002-07-02
US20070071812A1 (en) 2007-03-29
NZ516416A (en) 2003-10-31
EP1574214B1 (fr) 2006-10-04
SK287484B6 (sk) 2010-11-08
DE60019120T2 (de) 2006-02-09
IS2157B (is) 2006-11-15
ATE291912T1 (de) 2005-04-15
EE04995B1 (et) 2008-04-15
CN1682707A (zh) 2005-10-19
ES2271924T3 (es) 2007-04-16
HRP20020111A2 (en) 2003-04-30
JP2003504331A (ja) 2003-02-04
HK1080391A1 (en) 2006-04-28
HUP0202338A2 (en) 2002-10-28
TR200200008T2 (tr) 2002-06-21
BG106280A (en) 2002-08-30
DE60031184T2 (de) 2007-08-23
PL352307A1 (en) 2003-08-11
FR2795961B1 (fr) 2004-05-28
PT1574214E (pt) 2007-01-31
IL147499A0 (en) 2002-08-14
CN1682707B (zh) 2010-05-05
DE60039313D1 (de) 2008-08-07
RS50035B (sr) 2008-11-28
JP4841092B2 (ja) 2011-12-21
EP1523983A1 (fr) 2005-04-20
EE200200011A (et) 2003-02-17
ES2235919T3 (es) 2005-07-16
DK1574214T3 (da) 2007-01-22
IL147499A (en) 2007-03-08
KR20060073549A (ko) 2006-06-28
PT1194140E (pt) 2005-07-29

Similar Documents

Publication Publication Date Title
HRP20020111B1 (en) Pharmaceutical composition containing fenofibrate and preparation method
HUT52030A (en) Fungicide, insecticide and miticide compositions containing propene-carboxylic acid derivatives as active components and process for producing the active components
HUP0103567A2 (hu) ORL-1 receptor agonistaként alkalmazható 2-helyzetben helyettesített 1-piperidil-benzimidazol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyászati készítmények
CA2225286A1 (en) A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof
BR0012250A (pt) Processo de fabricação de grânulos revestidos com gosto mascarado, e liberação imediata do princìpio ativo, grânulo revestido, comprimido multiparticulado de dissolução rápida e comprimido de hidrodispersibilidade rápida
WO2000023407A3 (en) Ureido-thiobutyric acid derivatives as ppar-agonists
WO2001095856A3 (en) Urea derivative useful as an anti-cancer agent and process for preparing same
WO2001029055A3 (fr) Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant
EA199700093A1 (ru) ЛЕКАРСТВЕННЫЕ ФОРМЫ ДЛЯ ПЕРОРАЛЬНОГО ВВЕДЕНИЯ, СОДЕРЖАЩИЕ β-ЛАКТАМНЫЙ АНТИБИОТИК
HUP9802995A3 (en) Substituted sulphonylamino (thio)carbonyl derivatives, intermediates, thereof herbicide compositions containing these compounds as active ingredients, process for the preparation and use of the compounds and compositions
BG102555A (en) Microgranules of delayed release containing dilthiazem as active component
HUT47794A (en) Insecticide, acaricide and nematocide compositions containing pyridazinone derivatives as active components and process for producing the active components
EP1020444A4 (en) 6-PHENOXYPICOLINIC ACID, ALKYLIDENEHYDRAZIDE DERIVATIVES, THEIR PRODUCTION PROCESS, AND HERBICIDE
AU4315796A (en) Hydantoin derivatives, process for producing the same and herbicides comprising the same as active ingredients
TR199901044T2 (en) Endos�lfan-mikrokaps�l da��l�m�.
HUP0000982A3 (en) Process for the preparation of 1,1-dioxo-penicillanic acid derivatives
HUP0004386A3 (en) Methylenebisphosphonic acid derivatives, process for producing them and medicaments containing the same as active agent
AU1465995A (en) N-phenyltetrahydrophthalamic acid derivative, process for producing the same, and herbicide containing the same as active ingredient
EP1129712A4 (en) PREPARATIONS OF QUINOLINONE DERIVATIVES AND THEIR PRODUCTION METHOD